Press Releases Theraclion

Equities

ALTHE

FR0010120402

Market Closed - Euronext Paris Other stock markets 11:27:14 2024-04-29 am EDT			5-day change	1st Jan Change
0.375 ^EUR	+4.17%		+4.17%	-3.35%

Mar. 27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion Announces 2023 Financial Results and Continues Its Roadmap	Mar. 27	BU
Theraclion : announces 2023 financial results and continues its roadmap	Mar. 27	PU
Theraclion : Présentation AGM – 29 juin 2023	Dec. 20	PU
Theraclion : Presentation AGM 29 juin 2023	23-07-24	PU
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	23-04-28	PU
THERACLION : SUCESSFULLY REPRESENTATED AT THE 8TH INTERNATIONAL SYMPOSIUM ON FOCUSED ULTRASOUND	22-11-14	PU
Theraclion : Last patient of first SONOVEIN® US study has been treated	22-10-17	PU
Theraclion : AGM 2022 Présentation	22-06-30	PU
Theraclion : Inside Information / Other news releases	22-01-24	PU
Theraclion : is deploying its scalable robotic platform SONOVEIN® in Europe	21-12-14	PU
Theraclion : results show strong recovery, allowing ambitious plans	21-09-23	PU
Theraclion : FDA approves the 1st trial with Theraclion’s vein therapy in the US	21-09-20	PU
Theraclion : Bernard Sabrier and Unigestion pass the 20% threshold, proof of confidence in the company’s development	21-06-10	PU
Theraclion : UVA Cancer Center to expand use of Theraclion’s HIFU system in cancer treatment research.	21-06-02	PU
Theraclion : In 2020, Theraclion has succeeded a crucial step for its technology.	21-03-22	PU
In 2020, Theraclion Has Succeeded a Crucial Step for Its Technology: Results Allow Further Expansion for the Next Two Years	21-03-22	BU
Theraclion : Strategy Is in Place for 2021 Despite the Impact of Covid-19 on Sales Revenues For 2020	21-01-19	BU
Theraclion : strategy is in place for 2021 despite the impact of Covid-19 on sales revenues for 2020	21-01-19	PU
Theraclion : Renewed Investor Confidence in Theraclion	20-12-17	BU
Theraclion : Positive and Differentiated Results for Theraclion’s Non-invasive Varicose Vein Treatment Technology Revealed at The 34th AVLS	20-10-21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Theraclion

Equities

ALTHE

FR0010120402

Press Releases

Filters